CXCR4 in colorectal cancer: from prognostic marker to immunotherapy guide?

Key Points

• The research focuses on understanding the role of cxcr4 in colorectal cancer and its potential as both a prognostic marker and a guide for immunotherapy.
• Literature review on cxcr4 in colorectal cancer
• Analysis of cxcr4 expression levels in tumor samples
• Evaluation of therapeutic implications for immunotherapy
• Cxcr4 is identified as a significant biomarker associated with poor outcomes in metastatic colorectal cancer.
• Higher cxcr4 levels correlate with increased tumor aggressiveness and metastasis.
• Potential strategies involving cxcr4 targeting in immunotherapy are discussed.

Abstract